StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) bonds

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Elite Pharmaceuticals reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Mar 31, 2022

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Elite Pharmaceuticals's 10-Q for the period ended Jun 30, 2026

IssueCouponMaturesAmount issuedCarrying value
Njeda Bonds Series A Notes6.50%Sep 1, 2030$3.66M–
Loans Payable–––$2.22M
NJEDA Bonds–––$850.00K
Njeda Bonds Noncurrent–––$655.10K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?